Martínez-García L, González-Alba JM, Baquero F, Cantón R, Galán JC.

Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases.

Mbio 2018. 9(3): . Nº de citas: 9

[doi:10.1128/mBio.02109-17]

Escudero JA, MacLean RC, San Millan A.

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS 2018. (135): .

[doi:10.3791/57386]

Fernández-Martínez M, Ruiz Del Castillo B, Lecea-Cuello MJ, Rodríguez-Baño J, Pascual Á, Martínez-Martínez L.

Prevalence of Aminoglycoside-Modifying Enzymes in Escherichia coli and Klebsiella pneumoniae Producing Extended Spectrum -Lactamases Collected in Two Multicenter Studies in Spain.

MICROBIAL DRUG RESISTANCE 2018. 24(4): 367-376. Nº de citas: 16

[doi:10.1089/mdr.2017.0102]

Canton R, Morrissey I, Vila J, Tato M, García-Castillo M, López Y, Gargallo-Viola D, Zsolt I.

Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates.

Future Microbiology 2018. 13(6): 3-19. Nº de citas: 18

[doi:10.2217/fmb-2017-0289]

Rodriguez-Beltran J, Hernandez-Beltran JCR, DelaFuente J, Escudero JA, Fuentes-Hernandez A, MacLean RC, Peña-Miller R, San Millan A.

Multicopy plasmids allow bacteria to escape from fitness trade-offs during evolutionary innovation.

Nature Ecology & Evolution 2018. 2(5): 873-881. Nº de citas: 36

[doi:10.1038/s41559-018-0529-z]

Angers-Loustau A, Petrillo M, Bengtsson-Palme J, Berendonk T, Blais B, Chan KG, Coque TM, Hammer P, Heß S, Kagkli DM, Krumbiegel C, Lanza VF, Madec JY, Naas T, O'Grady J, Paracchini V, Rossen JWA, Ruppé E, Vamathevan J, Venturi V, Van den Eede G.

The challenges of designing a benchmark strategy for bioinformatics pipelines in the identification of antimicrobial resistance determinants using next generation sequencing technologies.

F1000Research 2018. 7: 459-459.

[doi:10.12688/f1000research.14509.2]

Cantón R, Loza E, Aznar J, Barrón-Adúriz R, Calvo J, Castillo FJ, Cercenado E, Cisterna R, González-Romo F, López-Hontangas JL, Suárez-Barrenechea AI, Tubau F, Molloy B, López-Mendoza D.

Antimicrobial susceptibility trends and evolution of isolates with extended spectrum ß-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015).

REVISTA ESPANOLA DE QUIMIOTERAPIA 2018. 31(2): 136-145. Nº de citas: 9

Navarro-San Francisco C, Ruiz-Garbajosa P, Cantón R.

The what, when and how in performing and interpreting microbiological diagnostic tests in skin and soft tissue infections.

CURRENT OPINION IN INFECTIOUS DISEASES 2018. 31(2): 104-112. Nº de citas: 9

[doi:10.1097/QCO.0000000000000433]

Díez-Aguilar M, Conejo MC, Morosini MI, Palop NT, Gimeno C, Cantón R, Pascual Á.

Susceptibility testing and detection of ß-lactam resistance mechanisms in Enterobacteriaceae: a multicentre national proficiency study.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2018. 51(4): 612-619. Nº de citas: 3

[doi:10.1016/j.ijantimicag.2017.12.008]

Abodakpi H, Chang KT, Sánchez Díaz AM, Cantón R, Lasco TM, Chan K, Sofjan AK, Tam VH.

Prevalence of extended-spectrum beta-lactamase and carbapenemase-producing bloodstream isolates of Klebsiella pneumoniae in a tertiary care hospital.

JOURNAL OF CHEMOTHERAPY 2018. 30(2): 115-119. Nº de citas: 6

[doi:10.1080/1120009X.2017.1399233]

Del Campo-Moreno R, Alarcón-Cavero T, D'Auria G, Delgado-Palacio S, Ferrer-Martínez M.

Microbiota and Human Health: characterization techniques and transference.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2018. 36(4): 241-245. Nº de citas: 2

[doi:10.1016/j.eimc.2017.02.007]

Toledo D, Soldevila N, Torner N, Pérez-Lozano MJ, Espejo E, Navarro G, Egurrola M, Domínguez Á.

Factors associated with 30-day readmission after hospitalisation for community-acquired pneumonia in older patients: a cross-sectional study in seven Spanish regions.

BMJ open 2018. 8(3): . Nº de citas: 17

[doi:10.1136/bmjopen-2017-020243]

Ares-Arroyo M, Bernabe-Balas C, Santos-Lopez A, Baquero MR, Prasad KN, Cid D, Martin-Espada C, San Millan A, Gonzalez-Zorn B.

PCR-Based Analysis of ColE1 Plasmids in Clinical Isolates and Metagenomic Samples Reveals Their Importance as Gene Capture Platforms.

FRONTIERS IN MICROBIOLOGY 2018. 9: 469-469. Nº de citas: 17

[doi:10.3389/fmicb.2018.00469]

Rondy M, Kissling E, Emborg HD, Gherasim A, Pebody R, Trebbien R, Pozo F, Larrauri A, McMenamin J, Valenciano M, I-MOVE/I-MOVE+ group.

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies.

Eurosurveillance 2018. 23(9): . Nº de citas: 46

[doi:10.2807/1560-7917.ES.2018.23.9.18-00086]

Amani D, Emira N, Ismail T, Jamel E, Dominique S, Rosa DC, Mejdi S.

Extracellular enzymes and adhesive properties of medically important Candida spp. strains from landfill leachate.

MICROBIAL PATHOGENESIS 2018. 116: 328-334. Nº de citas: 1

[doi:10.1016/j.micpath.2018.01.042]

García-Castillo M, García-Fernández S, Gómez-Gil R, Pitart C, Oviaño M, Gracia-Ahufinger I, Díaz-Regañón J, Tato M, Cantón R.

Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2018. 51(3): 511-515. Nº de citas: 19

[doi:10.1016/j.ijantimicag.2018.01.011]

Bordallo-Cardona MÁ, Marcos-Zambrano LJ, Sánchez-Carrillo C, de la Pedrosa EGG, Cantón R, Bouza E, Escribano P, Guinea J.

Mutant Prevention Concentration and Mutant Selection Window of Micafungin and Anidulafungin in Clinical Candida glabrata Isolates.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2018. 62(3): . Nº de citas: 12

[doi:10.1128/AAC.01982-17]

Mouton JW, Muller AE, Canton R, Giske CG, Kahlmeter G, Turnidge J.

MIC-based dose adjustment: facts and fables.

The Journal of antimicrobial chemotherapy 2018. 73(3): 564-568. Nº de citas: 157

[doi:10.1093/jac/dkx427]